跳至主要内容
临床试验/NCT04282551
NCT04282551Unknown不适用

The Effect of Oligosaccharides Versus a Placebo on Bowel Habits in Children With Functional Constipation

Wageningen University and Research2 个研究点 分布在 1 个国家目标入组 198 人开始时间: 2020年6月24日最近更新:
适应症

试验速览

阶段
不适用
入组人数
198
试验地点
2
主要终点
Stool consistency

研究概览

简要总结

In the present randomised double blind controlled study, the investigators will study the effects of oligosaccharides vs a placebo on the change in stool consistency and stool frequency in children with functional constipation.

详细描述

Functional constipation (FC) in children is a common gastrointestinal (GI) disorder with a worldwide prevalence ranging from 0.7% to 29.6%. Complaints include infrequent bowel movement, painful defecation due to hard and/or large stools, fecal incontinence, and abdominal pain. Although the condition is rarely life-threatening, it strongly impairs quality of life. Oligosaccharides have been shown to relieve constipation symptoms in young adults and elderly. However, sufficient evidence is lacking linking oligosaccharides intake to improve symptoms in children with FC. The investigators hypothesize that oligosaccharides might be able to relieve symptoms of constipation in young children as well, among which softening stools.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 3 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Children who suffer from any other GI complaints than functional constipation, known structural GI abnormalities, or previous GI surgery
  • Any condition that would make it unsafe for the child to participate.
  • Children with clinically significant cardiac, vascular, liver, pulmonary, psychiatric disorders, severe renal insufficiency, human immunodeficiency virus, acquired immunodeficiency syndrome, hepatitis B or C or known abnormalities of haematology, urinalysis, or blood biochemistry
  • Children who are allergic to cow's milk or fish
  • Use of antibiotics or other medicines or food supplements, and breast milk-feeding, 4 weeks prior to the study, except for the allowed escape medication
  • Children that participate in another clinical trial

结局指标

主要结局

Stool consistency

时间窗: Stool consistency will be measured at different time points during a study period of 13 weeks.

Change in stool consistency measured by the a stool questionnaire; 5 points stool scale from 1 hard to 5 watery (modified Bristol Stool Form Scale)

次要结局

  • Stool consistency in number of cases (%)(These outcome measures will be measured at different time point during a study period of 13 weeks.)
  • Stool frequency in number of cases (%)(These outcome measures will be measured at different time point during a study period of 13 weeks.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Clara Belzer

Associate Professor

Wageningen University and Research

研究点 (2)

Loading locations...

相似试验